More importantly this show that Europe look at CE Mark (which was a major concern) to use the medical device, there's no doubt the 1st US clinical trial was stuff up by management but the 2nd US clinical trial were 33% of the time the 2 respiratory doctors at one of the most prodigious hospital couldn't even agree indicate how subjective respiratory disease diagnosis will always be if ResAppDx isn't used.
- Forums
- ASX - By Stock
- RAP
- RAP tech on Ch 7 Sydney?
RAP tech on Ch 7 Sydney?, page-43
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & MD
Charles Armstrong
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online